Assessment of Nociception and Inflammatory/Tissue Damage Biomarkers in a Post-COVID-19 Animal Model
Eva M. Sánchez-Robles, Carmen Rodríguez-Rivera, Nancy Paniagua Lora, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Lars Arendt-Nielsen, Cesar Fernández-de-las-Peñas, Visitación López-Miranda · 2025
Read Assessment of Nociception and Inflammatory/Tissue Damage Biomarkers in a Post-COVID-19 Animal Model by Eva M. Sánchez-Robles, Carmen Rodríguez-Rivera, Nancy Paniagua Lora, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Lars Arendt-Nielsen, Cesar Fernández-de-las-Peñas, Visitación López-Miranda (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785914.txt.
Description
Long after COVID-19, many patients report lasting pain, and a mouse model that copies that pain would help labs find its source. Eva Sánchez-Robles and co-authors test one such model in a 2025 study, using female mice built to carry the human doorway the virus uses. Infected mice were checked for heat pain over four weeks, then blood and nerve tissue were read for inflammation.
Heat pain thresholds did not split clearly between infected and clean mice, though a drift toward lower thresholds appeared late. Blood showed a mild system-wide inflammation. The leg nerve showed no rise in the inflammation markers the team stained for. The authors conclude this virus strain, in this model, does not reproduce the pain seen in people, and other paths must be explored.
Catalog record
| CREATOR | Eva M. Sánchez-Robles, Carmen Rodríguez-Rivera, Nancy Paniagua Lora, Esperanza Herradón Pliego, Carlos Goicoechea Garcia, Lars Arendt-Nielsen, Cesar Fernández-de-las-Peñas, Visitación López-Miranda |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |